TrianglePUBLICATIONS · 9060537
Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 1997 Mar
- First author
- Muggia FM
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Muggia FM
- type
- Author
- name
- Hainsworth JD
- type
- Author
- name
- Jeffers S
- type
- Author
- name
- Miller P
- type
- Author
- name
- Groshen S
- type
- Author
- name
- Tan M
- type
- Author
- name
- Roman L
- type
- Author
- name
- Uziely B
- type
- Author
- name
- Muderspach L
- type
- Author
- name
- Garcia A
- type
- Author
- name
- Burnett A
- type
- Author
- name
- Greco FA
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Muggia FM
- type
- Author
- name
- Hainsworth JD
- type
- Author
- name
- Jeffers S
- type
- Author
- name
- Miller P
- type
- Author
- name
- Groshen S
- type
- Author
- name
- Tan M
- type
- Author
- name
- Roman L
- type
- Author
- name
- Uziely B
- type
- Author
- name
- Muderspach L
- type
- Author
- name
- Garcia A
- type
- Author
- name
- Burnett A
- type
- Author
- name
- Greco FA
- type
- Author
- bibliography ids
- nci-bib-9b6c437a5eb140625c425710
- book metadata
- content sha256
- 1260c1485bc8d7b7d36d8dc174155c38ad811a0f71dd590a1e2fc112cf1bb71f
- document type
- citation
- dois
- 10.1200/JCO.1997.15.3.987
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:9060537
- immutable id
- pubmed:9060537@1260c1485bc8d7b7d36d8dc174155c38ad811a0f71dd590a1e2fc112cf1bb71f
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 3
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 987-93
- volume
- 15
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 9060537
- provenance
- batch id
- 629590480cca3a097fa8
- provider
- NCBI PubMed ESummary
- record sha256
- 2afaf79c585a1268c3d0f3b928e9f511314e8c39a3af8b66428f5e0ab9f8fe1a
- response sha256
- 0eb1cec7011436204408643f1cea7888e97d436038d0a09eaecfd9b32db84919
- retrieved at
- 2026-09-09T23:45:26.993225+00:00
- publication date
- display
- 1997 Mar
- precision
- month
- year
- 1997
- publication types
- Clinical Trial
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/9060537/
- title
- Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.
Preserved source evidence · Not medical advice